Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of desonide and mucopolysaccharide polysulfate is used primarily for treating various forms of eczema, including infantile eczema and chronic eczema. This combination has shown better therapeutic efficacy compared to desonide alone. Desonide is a topical corticosteroid that works by activating natural substances in the skin to reduce swelling, redness, and itching. It's available in various forms including cream, ointment, gel, foam, and lotion. Mucopolysaccharide polysulfate (MPS) cream, also known as hirudoid cream, is a heparinoid-containing product that functions as an effective moisturizer for various skin conditions. It helps restore skin barrier function by decreasing transepidermal water loss and increasing stratum corneum hydration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on desonide + mucopolysaccharide polysulfate.